IL33 and diabetic kidney disease: In this progressive model of DKD, inhibition of IL-33/ST2 signaling translated into a significant protection against functional and structural kidney damage compared with control animals: progression of albuminuria reduced by 68.7% (P = 0.0001) and glomerular damage decreased by 13% (P = 0.0331) (Figure 1g and h).